RecruitingNCT04370626

The Canadian Prospective Pragmatic Perilunate Outcomes Trial

The Canadian Prospective Pragmatic Perilunate Outcomes Trial (The C3PO Trial)


Sponsor

University of Calgary

Enrollment

450 participants

Start Date

Sep 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This is a unique three-fold prospective and retrospective study. With this approach, all previous and current PLIs presented at participating study sites will have the potential to be included in the study. Our goal is to collect all relevant injury and surgical parameters of the Perilunate spectrum. The investigators plan to identify each hospital within Canada that normally treats PLIs and to record injury and demographic information on each PLI that occurs in this country over a two to three-year period. Our protocol includes scheduled two, five, and 10-year follow-up intervals.


Eligibility

Min Age: 14 YearsMax Age: 120 Years

Inclusion Criteria3

  • The subject is 14 years of age or older
  • The subject has been clinically diagnosed with a perilunate injury
  • The subject is willing to adhere to the study protocol including required post-operative therapy, all scheduled follow-up visits, evaluations, and questionnaires (if applicable).

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

South Health Campus

Calgary, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04370626


Related Trials